Listen to the podcaste on Spotify Here is a great short podcast with Celadon Pharmaceuticals Plc CEO James Short explaining how pharma-grade cannabis-based medicines might help the 8 million adults with untreatable chronic pain in the UK, and why the UK is uniquely placed to build a burgeoning industry. Fresh off becoming the only AIM-listed cannabinoid …
Celadon Pharmaceuticals Plc is proud to be featured in The Guardian newspaper today with a story titled “Inside one of the first licenced medical cannabis labs in Britain“. Click here to read the full story.
Celadon is this morning delighted to announce its admission to the London Stock Exchange AIM market, raising £8.5m and bringing the total raise in the past year to ~£20m. Our goal is to become the provider and partner of choice for researching and producing pharmaceutical-grade cannabinoid-based medicines. We have built an integrated supply chain and …
Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company specialising in the research, cultivation, manufacturing and supply of cannabinoid-based medicines. Its primary focus is on improving the quality of life for chronic pain sufferers, as well as exploring cannabinoid-based medicines for other conditions such as autism. Its UK facility comprises a laboratory designed to meet UK-GMP …
Input your search keywords and press Enter.